Localization Techniques for Non-Palpable Breast Lesions: Current Status, Knowledge Gaps, and Rationale for the MELODY Study (EUBREAST-4/iBRA-NET, NCT 05559411)

Simple Summary Most breast cancers are small and can be treated using breast-conserving surgery. Since these tumors are non-palpable, they require a localization step that helps the surgeon to decide which tissue needs to be removed. The oldest localization technique is a guidewire placed into the tumor before surgery, usually using ultrasound or mammography. Afterwards, the surgeon removes the tissue around the wire tip. However, this technique has several disadvantages: It can cause the patient discomfort, requires a radiologist or another professional specialized in breast diagnostics to perform the procedure shortly before surgery, and 15–20% of patients need a second surgery to completely remove the tumor. Therefore, new techniques have been developed but most of them have not yet been examined in large, prospective, multicenter studies. In this review, we discuss all available techniques and present the MELODY study that will investigate their safety, with a focus on patient, surgeon, and radiologist preference. Abstract Background: Surgical excision of a non-palpable breast lesion requires a localization step. Among available techniques, wire-guided localization (WGL) is most commonly used. Other techniques (radioactive, magnetic, radar or radiofrequency-based, and intraoperative ultrasound) have been developed in the last two decades with the aim of improving outcomes and logistics. Methods: We performed a systematic review on localization techniques for non-palpable breast cancer. Results: For most techniques, oncological outcomes such as lesion identification and clear margin rate seem either comparable with or better than for WGL, but evidence is limited to small cohort studies for some of the devices. Intraoperative ultrasound is associated with significantly higher negative margin rates in meta-analyses of randomized clinical trials (RCTs). Radioactive techniques were studied in several RCTs and are non-inferior to WGL. Smaller studies show higher patient preference towards wire-free localization, but little is known about surgeons’ and radiologists’ attitudes towards these techniques. Conclusions: Large studies with an additional focus on patient, surgeon, and radiologist preference are necessary. This review aims to present the rationale for the MELODY (NCT05559411) study and to enable standardization of outcome measures for future studies.

[1]  L. Scardina,et al.  Efficacy and Accuracy of Using Magnetic Seed for Preoperative Non-Palpable Breast Lesions Localization: Our Experience with Magseed , 2022, Current oncology.

[2]  T. Kühn,et al.  Current trends in diagnostic and therapeutic management of the axilla in breast cancer patients receiving neoadjuvant therapy: results of the German-wide NOGGO MONITOR 24 survey , 2022, Archives of Gynecology and Obstetrics.

[3]  D. van Klaveren,et al.  Diagnostic Accuracy of Radioactive Iodine Seed Placement in the Axilla With Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Node-Positive Breast Cancer. , 2022, JAMA surgery.

[4]  Su-Ju Lee,et al.  Exploiting the advantages of a wireless seed localization system that differentiates between the seeds: Breast cancer resection following neoadjuvant chemotherapy , 2022, Cancer reports.

[5]  J. Harvey,et al.  Results of shared learning of a new magnetic seed localisation device - A UK iBRA-NET breast cancer localisation study. , 2022, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[6]  Banys-Paluchowski Maggie,et al.  Twinkle artifact in sonographic breast clip visualization , 2022, Archives of Gynecology and Obstetrics.

[7]  T. Kühn,et al.  Intraoperative Ultrasound-Guided Excision of Non-Palpable and Palpable Breast Cancer: Systematic Review and Meta-Analysis. , 2022, Ultraschall in der Medizin.

[8]  I. Castellano,et al.  Carbon tattooing of axillary lymph nodes in breast cancer patients before neoadjuvant chemotherapy: A retrospective analysis , 2022, Tumori.

[9]  M. Lux,et al.  AGO Recommendations for the Surgical Therapy of Breast Cancer: Update 2022 , 2022, Geburtshilfe und Frauenheilkunde.

[10]  M. Lux,et al.  AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2022 , 2022, Breast Care.

[11]  T. Kühn,et al.  False-negative rate in the extended prospective TATTOO trial evaluating targeted axillary dissection by carbon tattooing in clinically node-positive breast cancer patients receiving neoadjuvant systemic therapy , 2022, Breast Cancer Research and Treatment.

[12]  M. Kerin,et al.  Optimal localization strategies for non-palpable breast cancers –A network meta-analysis of randomized controlled trials , 2022, Breast.

[13]  C. Clement,et al.  First experience with Sirius Pintuition ® - A novel magnetic localization system for breast cancer surgery , 2022, European Journal of Surgical Oncology.

[14]  A. Juette,et al.  Radio-Frequency Identifier Devices (RFIDs): Our Experience With Wireless Localisation in Non-palpable Breast Masses at a UK Tertiary Breast Imaging Unit , 2022, Cureus.

[15]  S. Down,et al.  Wire- and magnetic-seed-guided localization of impalpable breast lesions: iBRA-NET localisation study. , 2022, The British journal of surgery.

[16]  S. Jud,et al.  Evaluation of a Wireless Localization System for Nonpalpable Breast Lesions — Feasibility and Cost-effectiveness in Everyday Clinical Routine , 2022, In Vivo.

[17]  T. Ruers,et al.  Nationwide registry study on trends in localization techniques and reoperation rates in non-palpable ductal carcinoma in situ and invasive breast cancer. , 2021, The British journal of surgery.

[18]  C. Athanasiou,et al.  Comparative effectiveness of different localization techniques for non-palpable breast cancer. A systematic review and network meta-analysis. , 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[19]  U. Wazir,et al.  The Evolving Role of Radiofrequency Guided Localisation in Breast Surgery: A Systematic Review , 2021, Cancers.

[20]  T. Ruers,et al.  Randomized controlled trial comparing magnetic marker localization (MaMaLoc) with wire‐guided localization in the treatment of early‐stage breast cancer , 2021, The breast journal.

[21]  K. Enokido,et al.  Magnetically Guided Localization Using a Guiding-Marker System® and a Handheld Magnetic Probe for Nonpalpable Breast Lesions: A Multicenter Feasibility Study in Japan , 2021, Cancers.

[22]  James Harvey,et al.  A Novel Mixed-Methods Platform Study Protocol for Investigating New Surgical Devices, with Embedded Shared Learning: Ibra-net Breast Lesion Localisation Study , 2021, International journal of surgery protocols.

[23]  C. Ranjith,et al.  Magnetic Seed Localization (Magseed) for excision of impalpable breast lesions—The North Wales experience , 2021, The breast journal.

[24]  W. Kelder,et al.  Abstract GS1-10: Radioactive Iodine Seed placement in the Axilla with Sentinel lymph node biopsy after neoadjuvant chemotherapy in breast cancer: Results of the prospective multicenter RISAS trial , 2021 .

[25]  M. Bessems,et al.  Safety and performance of Sirius Pintuition – a novel wire-free and non-radioactive localization system for breast cancer surgery. , 2021 .

[26]  T. Kühn,et al.  Carbon tattooing for targeted lymph node biopsy after primary systemic therapy in breast cancer: prospective multicentre TATTOO trial. , 2021, The British journal of surgery.

[27]  M. L. Marinovich,et al.  Surgical outcomes after radioactive 125I seed versus hookwire localization of non-palpable breast cancer: a multicentre randomized clinical trial , 2020, The British journal of surgery.

[28]  M. Specht,et al.  Retrospective Review of Pre-operative Radiofrequency Tag Localization of Breast Lesions in 848 Patients. , 2020, AJR. American journal of roentgenology.

[29]  A. Carmichael,et al.  A multicentre prospective feasibility study of carbon dye tattooing of biopsied axillary node and surgical localisation in breast cancer patients , 2020, Breast Cancer Research and Treatment.

[30]  S. Allen,et al.  Patient and clinician satisfaction and clinical outcomes of Magseed compared with wire-guided localisation for impalpable breast lesions , 2020, Breast Cancer.

[31]  J. Harvey,et al.  Impalpable breast lesion localisation, a logistical challenge: results of the UK iBRA-NET national practice questionnaire , 2020, Breast Cancer Research and Treatment.

[32]  S. Lowes,et al.  Use of Hologic LOCalizer radiofrequency identification (RFID) tags to localise impalpable breast lesions and axillary nodes: experience of the first 150 cases in a UK breast unit. , 2020, Clinical radiology.

[33]  M. Michell,et al.  Reflector-guided Localization of Non-palpable Breast Lesions: The First Reported European Evaluation of the SAVI SCOUT® System , 2020, AntiCancer Research.

[34]  K. Mokbel,et al.  Savi Scout® Radar Localisation of Non-palpable Breast Lesions: Systematic Review and Pooled Analysis of 842 Cases , 2020, AntiCancer Research.

[35]  W. V. van Harten,et al.  Early budget impact analysis on magnetic seed localization for non-palpable breast cancer surgery , 2020, PloS one.

[36]  J. Felmlee,et al.  How to Safely Perform Magnetic Resonance Imaging-guided Radioactive Seed Localizations in the Breast , 2020, Journal of clinical imaging science.

[37]  S. Brucker,et al.  Axillary ultrasound for prediction of response to neoadjuvant therapy in the context of surgical strategies to axillary dissection in primary breast cancer: a systematic review of the current literature , 2020, Archives of Gynecology and Obstetrics.

[38]  F. Wright,et al.  Results of a phase I, non-randomized study evaluating a Magnetic Occult Lesion Localization Instrument (MOLLI) for excision of non-palpable breast lesions , 2019, Breast Cancer Research and Treatment.

[39]  T. Ahern,et al.  Intraoperative Ultrasound Guidance With an Ultrasound‐Visible Clip: A Practical and Cost‐effective Option for Breast Cancer Localization , 2019, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[40]  J. Harvey,et al.  Is the future magnetic? Magseed localisation for non palpable breast cancer. A multi-centre non randomised control study. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[41]  I. Rubio,et al.  Learning curves in intraoperative ultrasound guided surgery in breast cancer based on complete breast cancer excision and no need for second surgeries. , 2019, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[42]  A. Kusske,et al.  Microchipping the breast: an effective new technology for localizing non-palpable breast lesions for surgery , 2019, Breast Cancer Research and Treatment.

[43]  M. Michell,et al.  Wireless Breast Localization Using Radio-frequency Identification Tags: The First Reported European Experience in Breast Cancer , 2019, In Vivo.

[44]  P. Tsikouras,et al.  Radioactive seed localization and wire guided localization in breast cancer: A systematic review and meta-analysis. , 2019, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[45]  B. Niell,et al.  SAVI SCOUT® localization of breast lesions as a practical alternative to wires: Outcomes and suggestions for trouble-shooting. , 2018, Clinical imaging.

[46]  Julie Morris,et al.  Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study , 2018, Breast Cancer Research and Treatment.

[47]  G. Irwin,et al.  Current margin practice and effect on re-excision rates following the publication of the SSO-ASTRO consensus and ABS consensus guidelines: a national prospective study of 2858 women undergoing breast-conserving therapy in the UK and Ireland. , 2017, European journal of cancer.

[48]  K. Thavorn,et al.  Radioactive Seed Localization Versus Wire-Guided Localization for Nonpalpable Breast Cancer: A Cost and Operating Room Efficiency Analysis , 2017, Annals of Surgical Oncology.

[49]  Thomas L Klausen,et al.  Radioactive Seed Localization or Wire-guided Localization of Nonpalpable Invasive and In Situ Breast Cancer: A Randomized, Multicenter, Open-label Trial , 2017, Annals of surgery.

[50]  G. Karadeniz Cakmak,et al.  Surgeon performed continuous intraoperative ultrasound guidance decreases re-excisions and mastectomy rates in breast cancer. , 2017, Breast.

[51]  M. K. Hayes Update on Preoperative Breast Localization. , 2017, Radiologic clinics of North America.

[52]  S. Meijer,et al.  Intraoperative ultrasound guidance in breast-conserving surgery shows superiority in oncological outcome, long-term cosmetic and patient-reported outcomes: Final outcomes of a randomized controlled trial (COBALT). , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[53]  I. Vejborg,et al.  Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery , 2017, JAMA surgery.

[54]  F. Demirkazık,et al.  Comparison of wire-guided localization and radio-guided occult lesionlocalization in preoperative localization of nonpalpable breast lesions. , 2016, Turkish journal of medical sciences.

[55]  F. Schnabel,et al.  A Prospective, Single Arm, Multi-site, Clinical Evaluation of a Nonradioactive Surgical Guidance Technology for the Location of Nonpalpable Breast Lesions during Excision , 2016, Annals of Surgical Oncology.

[56]  A. Kheradmand,et al.  Applicability of Radioguided Occult Lesion Localization for NonPalpable Benign Breast Lesions, Comparison with Wire Localization, a Clinical Trial. , 2016, Asian Pacific journal of cancer prevention : APJCP.

[57]  Carlos Duarte,et al.  Randomized controlled clinical trial comparing radioguided occult lesion localization with wire-guided lesion localization to evaluate their efficacy and accuracy in the localization of nonpalpable breast lesions. , 2016, Surgery.

[58]  T. Frazier,et al.  A Randomized Prospective Comparison of Patient‐Assessed Satisfaction and Clinical Outcomes with Radioactive Seed Localization versus Wire Localization , 2016, The breast journal.

[59]  P. Whitworth,et al.  Pilot Study of a New Nonradioactive Surgical Guidance Technology for Locating Nonpalpable Breast Lesions , 2016, Annals of Surgical Oncology.

[60]  Katrin Jensen,et al.  Localization techniques for guided surgical excision of non-palpable breast lesions. , 2015, The Cochrane database of systematic reviews.

[61]  Murray A Reicher,et al.  A prospective clinical study to evaluate the safety and performance of wireless localization of nonpalpable breast lesions using radiofrequency identification technology. , 2015, AJR. American journal of roentgenology.

[62]  E. Rutgers,et al.  Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure. , 2015, Annals of surgery.

[63]  C. Loo,et al.  Heading toward radioactive seed localization in non‐palpable breast cancer surgery? A meta‐analysis , 2015, Journal of surgical oncology.

[64]  Juan Pablo Salazar,et al.  Intraoperative Ultrasound-Guided Lumpectomy Versus Mammographic Wire Localization for Breast Cancer Patients After Neoadjuvant Treatment , 2015, Annals of Surgical Oncology.

[65]  C. Goldsmith,et al.  A cosmesis outcome substudy in a prospective, randomized trial comparing radioguided seed localization with standard wire localization for nonpalpable, invasive, and in situ breast carcinomas. , 2014, American journal of surgery.

[66]  S. Sapareto,et al.  Monte Carlo simulation to analyze the cost-benefit of radioactive seed localization versus wire localization for breast-conserving surgery in fee-for-service health care systems compared with accountable care organizations. , 2014, AJR. American journal of roentgenology.

[67]  R. Agha,et al.  How can we improve surgical research and innovation?: the IDEAL framework for action. , 2013, International journal of surgery.

[68]  J. Dai,et al.  Intraoperative Ultrasound Guidance Is Associated with Clear Lumpectomy Margins for Breast Cancer: A Systematic Review and Meta-Analysis , 2013, PloS one.

[69]  Emerson Gasparetto,et al.  Magnetic resonance imaging-radioguided occult lesion localization (ROLL) in breast cancer using Tc-99m macro-aggregated albumin and distilled water control , 2013, BMC Medical Imaging.

[70]  M. Ramos,et al.  Ultrasound-guided excision combined with intraoperative assessment of gross macroscopic margins decreases the rate of reoperations for non-palpable invasive breast cancer. , 2013, Breast.

[71]  Douglas G Altman,et al.  IDEAL framework for surgical innovation 2: observational studies in the exploration and assessment stages , 2013, BMJ.

[72]  I. B. Borel Rinkes,et al.  Efficacy of ‘radioguided occult lesion localisation’ (ROLL) versus ‘wire-guided localisation’ (WGL) in breast conserving surgery for non-palpable breast cancer: a randomised controlled multicentre trial , 2012, Breast Cancer Research and Treatment.

[73]  S. Muller,et al.  Optimising surgical accuracy in palpable breast cancer with intra-operative breast ultrasound--feasibility and surgeons' learning curve. , 2011, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[74]  Kenneth G A Gilhuijs,et al.  Radioactive Seed Localization of Breast Lesions: An Adequate Localization Method without Seed Migration , 2011, The breast journal.

[75]  M. Duce,et al.  Radioguided occult lesion localization versus wire-guided localization for non-palpable breast lesions: randomized controlled trial , 2011, Clinics.

[76]  C. Goldsmith,et al.  A Multicentered, Randomized, Controlled Trial Comparing Radioguided Seed Localization to Standard Wire Localization for Nonpalpable, Invasive and in situ Breast Carcinomas , 2011, Annals of Surgical Oncology.

[77]  Jian-Hua Fu,et al.  Radiocolloid in Combination with Methylene Dye Localization, Rather Than Wire Localization, is a Preferred Procedure for Excisional Biopsy of Nonpalpable Breast Lesions , 2010, Annals of Surgical Oncology.

[78]  M. Fraile,et al.  Radioguided localization of nonpalpable breast cancer lesions: randomized comparison with wire localization in patients undergoing conservative surgery and sentinel node biopsy. , 2009, AJR. American journal of roentgenology.

[79]  B. Bodanese,et al.  Radioguided breast surgery for occult lesion localization – correlation between two methods , 2008, Journal of experimental & clinical cancer research : CR.

[80]  Jung-Hyun Yang,et al.  The Value of Ultrasound-Guided Tattooing Localization of Nonpalpable Breast Lesions , 2007, Korean journal of radiology.

[81]  A. Luini,et al.  Occult Breast Lesion Localization plus Sentinel Node Biopsy (SNOLL): Experience with 959 Patients at the European Institute of Oncology , 2007, Annals of Surgical Oncology.

[82]  H. Medina-Franco,et al.  Radioguided Localization of Clinically Occult Breast Lesions (ROLL): A Pilot Study , 2007, The breast journal.

[83]  C. Kaufman,et al.  Intraoperative ultrasound facilitates surgery for early breast cancer , 2002, Annals of Surgical Oncology.

[84]  R. Rouzier,et al.  Tattooing Breast Cancers Treated with Neoadjuvant Chemotherapy , 2007, Annals of Surgical Oncology.

[85]  S. Pinder,et al.  Randomized clinical trial comparing radioisotope occult lesion localization and wire‐guided excision for biopsy of occult breast lesions , 2004, The British journal of surgery.

[86]  P. Dam,et al.  Real-time RT–PCR correlates with immunocytochemistry for the detection of disseminated epithelial cells in bone marrow aspirates of patients with breast cancer , 2004, British Journal of Cancer.

[87]  A. Rose,et al.  Carbon localisation of impalpable breast lesions. , 2003, Breast.

[88]  I. Rubio,et al.  Surgical Use of Breast Ultrasound , 2003, The Surgical clinics of North America.

[89]  S. Barter,et al.  The use of carbon suspension as an adjunct to wire localisation of impalpable breast lesions. , 2002, Clinical radiology.

[90]  T. Helbich,et al.  [Comparison of wire versus carbon localization of non-palpable breast lesions]. , 2002, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

[91]  G. Kilicoglu,et al.  Marking of nonpalpable breast lesions using a custom carbon suspension. , 2001, Acta radiologica.

[92]  J. Friedland,et al.  Randomized Prospective Evaluation of a Novel Technique for Biopsy or Lumpectomy of Nonpalpable Breast Lesions: Radioactive Seed Versus Wire Localization , 2001, Annals of Surgical Oncology.

[93]  M. Berlière,et al.  [Localization of non-palpable breast lesions with black carbon powder (experience of the Catholic University of Louvain)]. , 2001, Journal de radiologie.

[94]  A. Luini,et al.  Comparison of radioguided excision with wire localization of occult breast lesions , 1999, The British journal of surgery.

[95]  A. Imperiale,et al.  Pre-operative localization of non-palpable lesions in breast cancer by charcoal suspension. , 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[96]  B. Goldberg,et al.  Ultrasonography: an alternative to x-ray-guided needle localization of nonpalpable breast masses. , 1988, Surgery.

[97]  G. Svane A Stereotaxic Technique for Preoperative Marking of Non-Palpable Breast Lesions , 1983, Acta radiologica: diagnosis.